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Activity-regulated cytoskeleton-associated protein, Arc, is a major regulator of long-term
synaptic plasticity and memory formation. Here we reveal a novel interaction partner
of Arc, a resident endoplasmic reticulum transmembrane protein, calnexin. We show
an interaction between recombinantly-expressed GST-tagged Arc and endogenous
calnexin in HEK293, SH-SY5Y neuroblastoma and PC12 cells. The interaction was
dependent on the central linker region of the Arc protein that is also required
for endocytosis of AMPA-type glutamate receptors. High-resolution proximity-ligation
assays (PLAs) demonstrate molecular proximity of endogenous Arc with the cytosolic
C-terminus, but not the lumenal N-terminus of calnexin. In hippocampal neuronal
cultures treated with brain-derived neurotrophic factor (BDNF), Arc interacted with
calnexin in the perinuclear cytoplasm and dendritic shaft. Arc also interacted with
C-terminal calnexin in the adult rat dentate gyrus (DG). After induction of long-term
potentiation (LTP) in the perforant path projection to the DG of adult anesthetized rats,
enhanced interaction between Arc and calnexin was obtained in the dentate granule cell
layer (GCL). Although Arc and calnexin are both implicated in the regulation of receptor
endocytosis, no modulation of endocytosis was detected in transferrin uptake assays.
Previous work showed that Arc interacts with multiple protein partners to regulate
synaptic transmission and nuclear signaling. The identification of calnexin as a binding
partner further supports the role of Arc as a hub protein and extends the range of
Arc function to the endoplasmic reticulum, though the function of the Arc/calnexin
interaction remains to be defined.
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INTRODUCTION
Activity-regulated cytoskeleton-associated protein (Arc) has been established as a major
regulator of protein synthesis-dependent synaptic plasticity (Bramham et al., 2010; Korb and
Finkbeiner, 2011; Shepherd and Bear, 2011; Nikolaienko et al., 2017a). Arc synthesis is essential
for long-term forms of synaptic plasticity such as long-term potentiation (LTP), long-term
depression (LTD; Park et al., 2008; Waung et al., 2008) and homeostatic scaling (Shepherd
et al., 2006). These Arc-dependent changes in synaptic efficacy are thought to be important
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in a wide range of behavioral adaptations including long-term
memory formation (Plath et al., 2006; Minatohara et al., 2016).
As an immediate-early gene, basal Arc mRNA levels are low
but rapidly peak following learning-related stimuli or induction
of LTP by high-frequency stimulation (HFS) of afferents. Arc is
tightly regulated at several levels including mRNA transport and
degradation (Steward et al., 1998; Giorgi et al., 2007), translation
(Bloomer et al., 2008; Panja et al., 2009; Panja and Bramham,
2014), ubiquitination (Greer et al., 2010; Soulé et al., 2012; Mabb
et al., 2014), SUMOylation (Craig et al., 2012; Nair et al., 2017)
and phosphorylation (Gozdz et al., 2017; Nikolaienko et al.,
2017b).
The molecular role of Arc protein is intriguingly diverse,
likely owing to its flexible, hub-like properties (Myrum et al.,
2015). Arc is localized to neuronal synapses, but is also found
in the dendritic shaft, neuronal soma and the nucleus. At the
synapse, Arc has been shown to regulate endosomal trafficking
of AMPA-type glutamate receptors, presumably by regulating
dynamin GTPase activity (Chowdhury et al., 2006; Byers et al.,
2015; DaSilva et al., 2016). By binding presenilin 1, Arc is also
involved in the endosomal trafficking and proteolytic processing
of amyloid precursor protein and Notch1 (Alberi et al., 2011;
Wu et al., 2011), which suggest a governing role of Arc in
regulating protein sorting. Arc expression is also critical for
the stabilization of F-actin at activated synapses during LTP at
activated synapses (Messaoudi et al., 2007), it complexes with the
actin-binding protein Drebrin A (Messaoudi et al., 2007; Nair
et al., 2017) and affects spine density and morphology (Peebles
et al., 2010). Finally, Arc can regulate synaptic strength at the
level of gene expression by localizing to nuclear promyelocytic
leukemia bodies and controlling expression of the AMPA-type
glutamate receptors (Bloomer et al., 2007; Korb et al., 2013).
Despite Arc’s key role in memory consolidation processes and
enduring forms of synaptic plasticity, the molecular mechanisms
by which it carries these actions out remain unclear. To shed
light on the molecular context of these mechanisms, we sought
to identify novel Arc binding partners. Using a GST-based
pull-down assay and mass spectrometry, we found that Arc
interacts with the cytosolic domain of the transmembrane
endoplasmic reticulum (ER) protein, calnexin. The interaction
was confirmed by immunoprecipitations (IPs) and proximity-
ligation assays (PLAs), both in vitro and in vivo. Lastly, we also
begin to explore the possible functional role that Arc may play at
the surface of the ER.
MATERIALS AND METHODS
Construction, Expression and Purification
of GST-Arc
The Arc coding sequence of rat origin plus a C-terminal histidine
tag was inserted into the multiple cloning site of the pGEX
plasmid and the sequence was analyzed by DNA sequencing. The
plasmid was transformed into BL21 (DE3) CodonPlus competent
cells and plated on an agar plate containing 100 µg/ml ampicillin
and 34 µg/mL chloramphenicol. A 10 mL LB starter culture
was inoculated, grown overnight and diluted in 500 ml LB
containing 100µg/mL ampicillin and 34µg/ml chloramphenicol
in a bacterial shaker at 250 rpm at 37◦C until OD600 = 0.6.
Isopropyl β-D-1-thiogalactopyranoside (IPTG) was added to a
final concentration of 0.6 mM and incubated for an additional
4 h. The culture was at 4◦C for 45 min at 4000 rpm.
The supernatant was removed, the pellet was resuspended in
lysis buffer (pH 8, 1 M phosphate buffer, 500 mM NaCl,
1 mM PMSF, 1× Roche Protease Inhibitor, 1% Triton-X100,
10 mM imidazole, 0.3% Sarkosyl, 10 mM 2-mercaptoethanol,
5% glycerol), sonicated on ice 3 × 5 s with 1 min interval. The
sample was centrifuged at 4◦C for 20 min at 14,000 rpm and the
supernatant was collected. A Qiagen Ni-NTA column was loaded
with 600 µL of equilibration buffer (pH 8, 0.1 M phosphate
buffer, 500 mM NaCl, 0.5% Triton-X100, 10 mM imidazole) and
spun down at 4◦C, 700 g for 4 min. Flow-through was discarded
and the column was reloaded with 600 µL of crude GST-Arc
lysate and spun down at 4◦C, 700 g for 4 min. Flow-through
was reloaded 2× on the same column and spun down at 4◦C,
700 g for 4 min each time. The column was then washed 3× with
600 µL wash buffer (equilibration buffer with 40 mM imidazole)
and spun down at 4◦C, 700 g for 4 min. A new collection tube
was attached to the column, 200 µL elution buffer (pH 8, 0.1 M
phosphate buffer, 50 mM NaCl, 200 mM imidazole, 1.0 mM
PMSF, 1× Roche protease inhibitor, 1.0 mM DTT) was added,
and Arc-GST was eluted by centrifugation at 4◦C, 700 g for
4 min. One additional fraction was eluted in 200 µl elution
buffer. Protein concentration was measured with a Nanodrop
spectrophotometer.
Cell Line Cultures
SH-SY5Y cells (human), HEK293 cells (human) and PC12 cells
(rat) were grown in Dulbecco’s modified Eagle medium
(DMEM; Sigma) supplemented with 10% fetal bovine serum,
penicillin/streptomycin and L-glutamine. Cells were seeded in
97 mm petri dishes or 6-well plates (Nunclon). Cells were
lysed in PBS containing 0.1% Triton-X100, 1 mM PMSF and
Roche Complete Protease Inhibitor Cocktail. The sample was
centrifuged at 4◦C for 20 min at 14,000 rpm, the supernatant
was collected and protein concentration was determined by
bicinchoninic acid assay (BCA assay; Thermo Scientific Pierce).
GST-Affinity Purification
HEK293 cell lysate containing 200 mg total protein and
5 mM DTT was mixed with 30 µL glutathione sepharose 4B
(GE-Healthcare/VWR 17-0756-01) and placed on a rotor for
1 h at 4◦C. The supernatant was collected and split into two
fractions. One fraction was incubated with glutathione beads
loaded with GST or GST-GFP. The other fraction was incubated
with beads loaded with GST-Arc, rotating at 4◦C overnight.
Beads were washed 4× with ice-cold PBS and spun down at
800 rpm. Samples were run on a 10% SDS-PAGE gel, stained for
3 h at room temperature (RT) with 0.25% Coomassie brilliant
blue dye R-250 (Bio Rad), and destained overnight at RT in
destaining solution.
In-Gel Digestion and Mass Spectrometry
Unidentified gel bands were cut into 1.0 mm cubes. Pieces were
washed in 100 µL wash solution at RT for 20 min with slow
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agitation. The supernatant was discarded and the wash was
repeated. Gel pieces were then dried in a vacuumed Rotavapor
until dry and 50 µL of 10 mM DTT was added and incubated
at 56◦C for 45 min. Samples were cooled, DTT was removed,
and 50 µL of 55 mM iodoacetamide was added and incubated
in the dark at RT for 30 min. Iodoacetamide was removed and
washed twice, as earlier described. Gel pieces were dried in a
vacuumed Rotavapor. To digest proteins, 30 µL of 3 ng/µL
trypsin from porsine were added to each sample and rehydrated
on ice for 30 min. Samples were incubated for 16 h at 37◦C
with slow agitation and then cooled and centrifuged at 1300 rpm
for 2 min. The supernatant was saved as the first extraction.
To extract peptides, 50 µL of 1% trifluoracetic acid was added
and incubated at RT for 20 min with gentle agitation. The
supernatant was added to the first extraction. Fifty microliter
of 60% ACN/0.1% TFA was added to the gel samples and
incubated for 20 min with gentle agitation. The supernatant
was pooled with the first two extractions. Extractions were
then dried in the vacuumed Rotavapor until 10–15 µL sample
remained.
Samples were then concentrated by STop And Go Extraction
(STAGE) tips. To make a STAGE tip, a Hamilton needle
(22 gauge) with a liquid chromatography tip was pressed against
an Empore 3M Extraction Disk to wedge a small piece in the
opening. The needle tip was placed into a 20 µL gel-loader
tip. Using 0.37 mm diameter capillary tubing, the piece of
Empore disk was pushed and packed into the gel-loader tip,
forming the column to be used for peptide concentration.
The gel-loader tip was cut 2–5 mm below this column. The
column was washed by slowly pushing 10 µL MeOH through
the tip with a syringe. The column was ‘‘wetted’’ with 10 µL
60% CAN/0.1% TFA, knocked down by flicking the gel-loader
tip, and 70% was pushed out. The column was ‘‘conditioned’’
with 10 µL 0.1% TFA, knocked down and 70% was pushed
out. Ten microliter of the sample was then added to the
column, knocked down and 70% was pushed out. The sample
was washed with 0.1% TFA and then dried by pushing air
through the column. The sample was eluted directly on a
MALDI plate with 1.0 µL alpha-cyano-4-hydroxycinnamic acid
(CHCA) matrix containing 50% CHCA-1 (60% CAN and
0.2% TFA) and 50% CHCA-2 (ACN:MeOH:H2O; 60:30:10).
A peptide calibration standard was also plated adjacent to
eluted samples. Samples were analyzed by MALDI-ToF-MS
UltraFlex instrumentation and Mascot was used to identify
peptides.
Arc Deletion Mutants, GFP-Arc and
mCherry-Calnexin
Arc cDNA residues 1–396 of rat origin were amplified with
HindIII and BamHI sites and ligated into the pEYFP-C1 vector
(Clontech). This full-length EYFP-tagged Arc was used to
amplify various regions of the Arc sequence (see ‘‘Results’’
Section). Suitable primers were used to yield a PCR product with
HindIII and BamHI sites, which were also ligated into pEYFP-
C1. The calnexin signal sequence required for ER localization
was inserted upstream of the mCherry fluorophore and the C-tail
was ligated into the multiple cloning site of mCherry-C1. Arc
cDNA of human origin was inserted into the multiple cloning
site of EGFP-C1. Constructs were checked by DNA sequencing
by the dideoxy chain termination method in an automated DNA
sequencer (ABI Prism 310).
Arc Deletion Mutant Transfection and
Immunoprecipitation (IP)
HEK293 cells at ∼80% confluency in 100 mm Petri dishes were
transfected with 8 µg Arc-EYFP plasmid deletion mutants, using
30 µL Lipofectamine 2000 reagent (Invitrogen) according to the
manufacturer’s protocol. After 24 h, cells were washed, lysed in
lysis buffer, scraped off and centrifuged. To IP calnexin, Protein
G Sepharose 4 Fast Flow beads (GE Healthcare) were washed
in PBS and then incubated with 2.5 µg calnexin C-20 antibody
(Table 1) for 1 h at RT. Beads were washed 3× in lysis buffer
and incubated with 500 µg total protein overnight at 4◦C. Bound
fractions were washed 3× in lysis buffer and analyzed by western
blot with GFP antibody (Table 1). A western blot of the input
fractions ensured that equal amounts of each yellow fluorescent
protein (YFP-Arc) construct were used in each IP.
SDS-PAGE and Western Blotting
Samples were separated by 10% SDS-PAGE and transferred onto
a nitrocellulosemembrane (Hybond-C; Amersham).Membranes
were blocked for 1 h at RT in Tris-buffered saline/0.1% Tween-
20 (TBST) and 3% non-fat dry milk. Primary antibodies were
diluted in blocking buffer containing TBST and 5% BSA and
applied on membranes overnight at 4◦C with constant shaking.
Following three washes with TBST, blots were incubated for 1 h
at RT in horseradish peroxidase-conjugated secondary antibody
diluted in TBST. Blots were then visualized using enhanced
chemiluminescence (ECLWestern Blotting Substrate; Pierce).
TABLE 1 | Antibodies used in this study (IF, immunofluorescence; IP, immunoprecipitation; WB, western blot).
Antibody Application Source Research resource identifier
Mouse anti-Arc IF1:200 Santa Cruz sc-17839 AB_626696
Rabbit anti-Arc IF1:1000 Synaptic Systems 156003 AB_887694
Goat anti calnexin IP Santa Cruz C-20 AB_2069146
Rabbit anti-calnexin N-term IF1:100 Enzo Life Sciences ADI-SPA-865 AB_10618434
Rabbit anti-calnexin C-term IF1:100 Enzo Life Sciences ADI-SPA-860 AB_10616095
Mouse anti-calnexin C-term IF1:200 Abnova M08 AB_1137121
Rabbit anti-GFP WB 0.5 µg/ml BioVision AB_222261
Goat anti-mouse Alexa Fluor 568 IF 1:500 Invitrogen A-11031 AB_144696
Goat anti-rabbit Alexa Fluor 647 IF 1:500 Invitrogen A-21245 AB_141775
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Primary Hippocampal Cell Culture
Hippocampi were dissected from E18 rat embryos (Wistar
RjHan:WI, Janvier labs, France), trypsinized, and plated at
30,000 cells/cm2 on Nr.1 glass coverslips coated with poly-D-
lysine (Sigma P6407). Cells were cultured in minimal essential
medium (Gibco 21430), supplemented with B27 (Gibco 17504),
antibiotics (Sigma-Aldrich P4083), 2 mM glutamine, 0.6%
glucose and 1 mM pyruvate, and conditioned on astrocyte
cultures. Where indicated, cells were treated with 100 ng/mL
human BDNF diluted in culture medium (Alomone labs; B-250)
for 4 h prior to fixation.
Immunofluorescence of Primary Cell
Culture
Cells were washed twice with PBS, fixed for 10 min with
4% paraformaldehyde/4% sucrose/PBS, washed with PBS,
permeabilized 10 min with 0.2% Triton-X-100/PBS, washed
with 50 mM NH4Cl/PBS, washed with PBS, and blocked for
1 h with 1% Roche Blocking Reagent (Roche 11096176001).
Primary antibodies (Table 1) were diluted in blocking buffer.
Coverslips with neurons were then inverted onto a drop of
antibody solution on parafilm in a humidified chamber at 4◦C
overnight. Coverslips were washed with PBS, then incubated on
a drop of secondary antibody (Table 1) in blocking buffer for 1 h
at RT, washed again with PBS, dipped in water andmounted with
ProLongGold Antifade Reagent containing DAPI (Invitrogen).
In Vivo Electrophysiology
Adult wild type male Sprague-Dawley rats (180–250 g;
NTac:SD; Taconic, Denmark) were anesthetized with urethane
(i.p. 1.5 g/kg). Rats were placed in a stereotaxic frame and body
temperature was maintained at 37◦C throughout the experiment.
A bipolar stimulation electrode (NE-200; 0.5 mm tip separation;
Rhodes Medical Instruments, Wood hills, CA, USA) was
positioned ipsilaterally into the perforant path (7.9 mm posterior
to Bregma, 4.2mm lateral tomidline and 2.5mmventral from the
brain surface). Evoked potential was measured by positioning an
insulated tungsten recording electrode (0.075mm; A-M Systems)
in the dentate gyrus (DG; 3.9 mm caudal to Bregma, 2.3 mm
lateral to the midline and 2.5–3.3 mm ventral from the brain
surface). The recording electrode was lowered into the brain
in 0.1 mm increments while monitoring the laminar profile
of the response waveform evoked by a 300–400 µA test pulse
stimulus. Following 20 min of baseline recording, HFS was
applied that consisted of 400 Hz, 8-pulse stimulus trains repeated
four times with 10 s between each train. HFS was applied three
times with 5 min between each session. Total HFS duration
was 10.5 min and the total pulse number was 96 (pulse-width
was 0.15 ms). The stimulus intensity used for HFS was twice of
that used for test pulses. Evoked responses were recorded for
120 min after HFS. Changes in the fEPSP slope were expressed
in percent of baseline (20 min preceding HFS). After recordings
were completed, the electrodes were removed, the animal was
transcardially perfused with 4% paraformaledhyde (PFA). The
brain was dissected and immersed in 4% PFA over night at
4◦C, then in 30% sucrose for 2 days at 4◦C. Twenty micrometer
coronal sections were cut using Tissue-Tek (Sakura), mounted on
Superfrost GOLD slides (Braunschweig, Germany), and stored
at 4◦C.
Immunofluorescence of Brain Sections
Antigen was retrieved by microwaving the mounted sections
for 10 min at 600 W in citrate buffer (10 mM sodium citrate,
0.05% Tween-20, pH 6.0). After cooling for 20 min, sections were
washed with PBS, permeabilized for 1.5 h with 0.5% Triton-X-
100/PBS, washed with PBS and blocked with 5% horse serum/5%
bovine serum albumin/PBS for 1 h at RT. Primary antibodies
(Table 1) were diluted in blocking buffer, incubated overnight at
4◦C, washed with PBS, then incubated with secondary antibodies
(Table 1) for 1 h at RT, washed for 30 min, mounted, and
coverslipped with ProLongGold Antifade Reagent containing
DAPI (Invitrogen).
Proximity Ligation Assay (PLA)
PLA was performed using the Duolink PLA Kit1 with
red (DUO92008) or orange (DUO92007) detection reagents,
anti-mouse minus probe (DUO92004), and anti-rabbit plus
probe (DUO92002). Manufacturer’s instructions were followed
for cultured neurons except that Roche blocking solution was
used. For F-actin staining, phalloidin-FITC (Sigma; 0.5 µg/mL)
was added in the penultimate wash step (wash buffer B) for
10 min. On brain sections, antigen retrieval was performed as
above, all incubation times and wash steps were doubled, and the
blocking buffer consisted of PBS containing 5% horse serum and
5% bovine serum albumin.
Images were taken on a Leica SP5 Laser Scanning confocal
microscope. Immunofluorescence of cultured neurons was
imaged with a 63× objective, a 561 nm laser for Alexa Fluor
568, a 633 laser for Alexa Fluor 647, and a 402 laser for
DAPI. Two optical sections were imaged—one at the dendritic
level and the other at the equatorial plane of the nucleus.
Dendritic PLA and phalloidin-FITC staining were imaged
using a 100× objective. For PLAs of cultured neurons, 24
z-stacks of 30 optical sections were taken from each coverslip
using a 40× objective, 402 nm excitation for DAPI, and
598 nm excitation for the red PLA signal or 561 nm for
the orange PLA. For PLA on brain sections, tile scans were
taken at 40× of 5× 4 z-stacks of 14 optical sections, covering
the DG.
Confocal stacks were analyzed with Imaris (Bitplane,
RRID:SCR_007370) using the 3D ‘‘spot’’ function for PLA
spots and ‘‘surface’’ function for nuclei. Optimal parameters
for these functions were determined using the negative control
(no antibodies) and positive control (Arc/Arc) from each
experiment and kept constant for all images belonging to
this experiment. In cell culture, PLA was quantified as the
number of spots divided by the number of cells. In brain
sections, the volumes of the molecular and granule cell layers
(GCLs) were measured by creating a ‘‘surface object’’, defined
by the lateral boundaries of the layers in XY direction, and
the tissue surface in Z direction. PLA was quantified as spot
density (PLA/mm3) inside this defined volume. All analyses
1http://sigma.com/duolink
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were performed by investigators blind to the experimental
conditions.
Transferrin Uptake Assay
SH-SY5Y human neuroblastoma cells were plated on
1 cm coverslips coated with collagen at a concentration
of 0.3 µg/mL and were maintained in complete DMEM.
Cells were transiently transfected at 70% confluence using
Lipofectamine 2000 (Invitrogen) and 2 µg of Arc-GFP, calnexin
C-terminus-mCherry, or both. Transferrin uptake assays
were performed 24 h after transfection. Cells were serum-
starved for 6 h prior to experiments (DMEM + 0.5% FBS).
Alexa Fluor 647-conjugated Transferrin (Life Technologies
T-23366) was added to each sample to a final concentration
of 15 µg/mL for 30 min on ice. The samples were then
returned to 37◦C for 15 min to restore endocytosis. Cells
were immediately placed on ice, washed twice with cold
PBS, and fixed using 1% PFA on ice for 30 min. Coverslips
were mounted using Prolong Gold anti-fade reagent with
DAPI.
All cells were imaged on a Leica SP2 confocal microscope
using a 60× objective. Identical settings were used for each
sample. Images were analyzed in ImageJ (RRID:SCR_003070).
Endocytosis was quantified by integrating the background-
subtracted Alexa Fluor 647 signal within the boundaries of
each cell. Transfected cells within each sample, determined
by the presence of GFP (Arc), mCherry (calnexin), or both,
were compared to internal controls (untransfected cells from
the same slide, in the same field of view), and conditions
were compared to each other using ANOVA after first
normalizing to internal controls for each replicate. All analyses
were performed by investigators blind to the experimental
conditions.
RESULTS
Arc Interacts with Calnexin
To identify novel Arc binding partners, we performed
GST-affinity purification using recombinantly-expressed
full-length rat Arc as bait (Arc-GST) and HEK293 cell
lysate (Figure 1). The prominent band at 81 kDa on the
Coomassie Brilliant Blue-stained SDS-PAGE gel was GST-
Arc, as confirmed by MALDI-TOF mass spectrometry. The
unidentified 90 kDa band seen in the experimental lane, but
not in the control (GST), was excised from the gel and also
analyzed by mass spectrometry (Figure 1A). The band was
identified as a transmembrane protein of the endoplasmic
reticulum, calnexin (Peptide Identification Score: 142; Peptides
identified: APVPTGEVYFADSFDR and KIPNPDFFEDLEPFR).
This finding was confirmed by probing GST-Arc-bound protein
on a western blot with anti-calnexin antibody (Figure 1B,
upper blot). GST-Arc also bound calnexin from non-stimulated
SH-SY5Y neuroblastoma cells, a neuronal cell line in which
Arc protein is endogenously expressed (Figure 1B, middle
blot). Since both HEK293 and SH-SY5Y cells are of human
origin, while our GST-Arc construct contained the rat sequence,
we also performed the GST-pull-down with rat PC12 cells,
FIGURE 1 | Activity-regulated cytoskeleton-associated protein (Arc) binds to
calnexin in GST pull-downs. (A) GST-affinity purification was performed with
HEK293 cell lysates and GST-Arc was used as bait. The prominent band at
81 kDa (right lane) was identified by mass spectrometry to be GST-Arc. The
unidentified band at 90 kDa in the experimental lane and not in the control
lane (containing GST, beads and lysate) was identified by mass spectrometry
to be calnexin. (B) The pull-down was repeated with lysates from three
different cell lines (HEK293, SH-SY5Y and PC12), transferred onto
nitrocellulose membranes, and were probed for calnexin.
a neuron-like cell line from the adrenal gland. Western blot
analyses confirmed the presence of calnexin in each GST-Arc
lane (Figure 1B).
Calnexin Requires Arc Residues 200–225
We then sought to determine the specific region of Arc protein
that binds to calnexin. We constructed plasmids encoding
the full-length rat Arc mRNA sequence, N-terminally fused
to YFP-Arc (Figure 2C). Three deletion mutants of this
construct, covering amino acids 1–100, 101–240 and 241–396,
respectively, were ectopically expressed in HEK293 cells and
subjected to IP with a calnexin-specific antibody. We found
that YFP-Arc (101–240) co-immunoprecipitated with calnexin,
while YFP-Arc (1–100) and YPF-Arc (241–396) failed to do so
(Figure 2A, left panel). To further narrow down the binding
region, we made sequential N-terminal deletions of YFP-Arc,
expressing amino acids 125–396, 150–396, 175–396, 200–396
and 225–396, respectively. Of these fragments, only one failed
to co-IP with calnexin, namely the shortest fragment YFP-Arc
(225–396). Since YFP-Arc (200–396) is only 25 amino acids
longer, but does co-IP with calnexin, Arc residues 200–225 are
essential for the interaction with calnexin (Figure 2B, left
panel).
Arc Binds to the Calnexin C-Terminus in
Hippocampal Neuronal Cultures
We then examined whether the interaction between Arc and
calnexin occurred in neurons. To induce Arc expression
in primary hippocampal neurons, we stimulated the cells
with brain-derived neurotrophic factor (BDNF) for 4 h. As
expected, Arc was detected in the nucleus, neuronal soma
and dendrites by immunofluorescence (Figure 3A). Since
calnexin is a transmembrane protein, with the C-terminus
located in the cytosol and the N-terminus located in the
lumen of the endoplasmic reticulum, we used antibodies
directed against either the C- or N-terminus. Both antibodies
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FIGURE 2 | Arc residues 200–225 are required for the interaction with calnexin. Co-immunoprecipitations (IPs) were performed with a calnexin antibody and yellow
fluorescent protein (YFP)-Arc deletion mutants. (A) Western blots probed with anti-GFP showed that full-length Arc (1–396) and Arc 101–240 bound to calnexin (left
panel). Similar expression levels of YFP-Arc deletion mutants were confirmed by immunoblotting lysates with anti-GFP antibody (input, right panel). (B) To narrow
down the binding region, co-IPs were repeated with progressive deletions of the Arc C-terminus. Arc 200–396 bound to calnexin while Arc 225–396 did not,
indicating that Arc residues 200–225 are required for calnexin to interact (left panel). Equal loading was again ensured by immunoblotting equal amounts of lysates
alone (input, right panel). (C) Alignment of the different Arc-deletion mutants. Numbers indicate amino acid positions. ± signs indicate positive or negative co-IPs with
calnexin.
resulted in very similar staining patterns—a reticular cytoplasmic
staining, including the nuclear membrane, and a weaker
punctate dendritic pattern (Figure 3A). Partial colocalization was
observed between Arc and both the calnexin C- and N-termini
in dendrites (Figure 3A, arrowheads). This colocalization was
rather sparse and merely indicates that a small fraction of
both Arc and calnexin localize at or near the same sub-cellular
site. To validate the interaction in neurons, we performed
PLAs, which detect protein proximity below 40 nm. PLAs
detect the proximity of two primary antibodies by labeling
the interaction site with a fluorophore, which is then detected
by fluorescence microscopy and quantified (Fredriksson et al.,
2002).
We used well-characterized Arc-directed antibodies for the
positive control, namely: (1) polyclonal rabbit anti-Arc, directed
against full-length Arc (Synaptic Systems); and (2) monoclonal
mouse anti-Arc (C-7, Santa Cruz). The probability of observing
proximity between these antibodies is high, given that they
bind to the same protein, thus forming intramolecular PLA.
Expectedly, PLA signal for Arc/Arc was low in naïve neuronal
cultures, in agreement with low basal Arc expression. After
induction of Arc expression with BDNF for 4 h, Arc/Arc
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FIGURE 3 | Arc binds to the calnexin C-terminus in hippocampal neuronal cultures. (A) Dual-immunofluorescence was performed with mouse anti-Arc C-7, rabbit
anti-calnexin C-terminal, or rabbit anti-calnexin N-terminal, respectively, in brain-derived neurotrophic factor (BDNF)-treated neurons. Partial colocalization was
observed between Arc and calnexin (both the N- and C-termini) in dendrites (arrowheads). Images are maximum intensity projections of two confocal sections: one
at the dendritic level, and the other at the equatorial plane of the nucleus, taken with a 63× objective. (B) Proximity ligation assays (PLAs) were performed in neurons
before and after BDNF treatment to confirm that Arc and calnexin are in close proximity (CnxC/Arc). Arc/Arc was used as a positive control. The images are
maximum projections of the whole cells using a 40× objective. PLA of negative controls was subtracted from the experimental samples before statistical analyses
(N = 3–4 independent experiments; 500–2, 200 cells/experiment; Wilcoxon matched-pairs signed rank test; Test statistics: W = 28, p = 0.016, z = 2.366). Dashed
lines connect the mean PLA signals of treated and non-treated cells in each independent experiment. (C) PLA was again performed in BDNF-treated neurons. The
F-actin stain phalloidin-FITC (green) was used in addition to PLA (red). PLA signals of Arc/Arc are abundant in the dendritic shaft and phalloidin-positive punctae
(arrowheads). Arc/Cnx signals are also found in the shaft, but were less abundant and were never found in spines. A 63× objective was used, and images are
maximum projections. Two independent experiments, about 100 cells each, were performed. (D) PLAs with Arc and calnexin antibodies recognizing the C-terminal
(CnxC) and N-terminal (CnxN) were performed in BDNF-treated neurons. Images are maximum projections using a 40× objective. The negative control (−/−) did not
contain primary antibodies. Right panel: values are expressed as mean ± SEM, where 700–2200 cells were analyzed per condition (Power analyses:
CnxN-Arc = 0.695, Arc-CnxC = 0.793, CnxC-Arc = 0.658). Arc was found in close proximity to the C-terminal, but not the N-terminal.
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FIGURE 4 | Arc and calnexin interact in rat brain sections following unilateral high-frequency stimulation (HFS). (A) Arc immunofluorescence of the contra- and
ipsilateral dentate gyrus (DG) following HFS. (B) Dual-immunofluorescence of Arc (red), calnexin C-terminal (green) and DAPI (blue) of the ipsilateral (receiving HFS)
DG, upper granule cell layer (GCL). (C) PLAs of HFS-treated tissue show Arc/Arc PLA signal (red) on both hemispheres, but Arc is robustly upregulated on the
ipsilateral side. White lines outline the boundaries of the layers of the DG. (D) 3D quantification of CnxC/Arc PLA signal showed a significant increase in the granule
cell layer (GCL), but not the molecular layer (ML) following HFS in the ipsilateral hemisphere (p = 0.04; N = 3 independent experiments; Power analyses:
GCL = 0.973, ML = 0.838). Spots counted in the negative control (−/−) were subtracted prior to statistical analyses. Dashed lines connect the respective mean PLA
signals of contra- and ipsi-lateral hemispheres in each independent experiment.
PLA was significantly upregulated (Figure 3B). Arc/Arc PLA
punctae were frequently found at phalloidin-labeled dendritic
punctae, most likely dendritic spines or synapses (Figure 3C).
They were also located in the dendritic shaft and neuronal
soma, but rarely in the nucleus. Arc/Arc PLA signal thus
confidently reflects Arc expression and is suitable as a positive
control.
To probe the interaction between Arc and calnexin, we
used the same antibodies as for immunofluorescence (rabbit
anti-calnexin C-terminus and mouse anti-Arc). This was
important, since Arc is a cytoplasmic protein (lacking a signal
peptide), and thus should only be able to interact with the
calnexin C-terminus. PLA between calnexin and Arc was low
in naïve neurons, and clearly positive in BDNF-treated neurons
(Figure 3B). Thus, PLA confirmed the proximity between Arc
and calnexin in cultured neurons. The Arc/calnexin C-terminus
PLA was readily observed in neuronal soma and dendritic shaft,
but was not in detected spines (Figure 3C).
We performed PLA with different combinations of
antibodies to minimize the possibility of false-positive
artifacts. PLA with rabbit anti-Arc and mouse anti-calnexin
C-terminus gave the same result as the reverse above,
which was significantly higher than the negative control
in BDNF-treated neurons (Figure 3D). When using the
rabbit anti-calnexin N-terminal antibody, PLA with Arc
was not significantly different from the negative controls,
although it seemed slightly elevated (Figure 3D). These
results reflect the further distance between the lumenal
N-terminus of calnexin and cytoplasmic Arc. Inconsistencies
during sample preparation (most importantly, membrane
permeabilization by Triton-X-100) could enhance or reduce this
proximity.
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Arc Binds to the Calnexin C-Terminus
In Vivo
PLAs were also performed in coronal brain sections following
HFS of the medial perforant path input to the DG of adult
anesthetized rats. HFS induces robust upregulation of Arc in the
granule cells of the DG, which is necessary for LTP maintenance
(Steward et al., 1998; Messaoudi et al., 2007). Two hours after
unilateral application of HFS, brains were transcardially
fixed, embedded, cryosectioned and subjected to dual
immunofluorescence or PLA. As expected, immunofluorescence
showed that Arc was robustly upregulated in the DG granule
cells of the ipsilateral hemisphere (Figure 4A), present both in
nuclei and neuronal soma of the GCL (Figure 4B). Within the
GCL, calnexin was seen in the perinuclear region of granule cell
soma, but was excluded from the nuclei, as expected (Figure 4B).
No obvious difference in calnexin expression was seen between
the ipsilateral and contralateral brain hemispheres (data not
shown). PLAs were then performed on neighboring sections
of the same brains. PLA between Arc/Arc followed the same
pattern as Arc expression—low in the contralateral hemisphere
and high in the ipsilateral GCL (Figure 4C). PLA between
calnexin and Arc is also significantly increased in the ipsilateral
hemisphere, particularly in the GCL, but not the molecular layer
(ML; Figures 4C,D). These assays demonstrate that the calnexin
C-terminus and Arc interact in the DG GCL following HFS
in vivo.
Arc-Calnexin C-Terminus Interaction Is Not
Involved in Endocytosis
Lastly, we began to investigate the role of the Arc-calnexin
interaction. Arc regulates endocytosis of AMPA receptors,
where co-overexpression of Arc with endophilin increases
AMPAR endocytosis (Chowdhury et al., 2006). Calnexin also
regulates endocytosis, but overexpression of full-length calnexin
or calnexin C-terminus impairs clathrin-mediated endocytosis
(Li et al., 2011). We therefore examined whether the interaction
affects receptor endocytosis by carrying out receptor uptake
assays in neuroblastoma cells. The amount of endocytosed
transferrin was quantified via confocal microscopy in three
independent experiments (n = 63, 51 and 39 cells, respectively).
No significant difference in endocytosis was detected between the
Arc, calnexin, and Arc/calnexin groups (Figure 5; p = 0.246).
DISCUSSION
The present work identifies calnexin, a transmembrane protein
of the ER, as a novel interaction partner of Arc. Calnexin is an
ubiquitously-expressed protein best known for its role in the
quality control of nascent glycoproteins in the ER (Caramelo and
Parodi, 2008). We show that Arc binds to the C-terminal tail
of calnexin in hippocampal neurons. We further show that Arc
residues 200–225 are required for the interaction with calnexin
(Figure 2). This region is at the border between the central
flexible hinge region (∼131–208) and the highly structured Arc
C-terminal domain (residues ∼209–365). A schematic of the
Arc-calnexin interaction is shown in Figure 6.
FIGURE 5 | Receptor endocytosis assay. (A) Arc, calnexin, or both were
overexpressed in SH-SY5Y neuroblastoma cells and the amount of
endocytosed transferrin was quantified via confocal microscopy. (B) No
significant difference in endocytosis was detected between the three groups
(p = 0.25; Power = 0.864). Scale bars = 10 µm.
BDNF treatment induces Arc expression and enhanced PLA
signal with calnexin in neuronal somata and dendritic shafts.
Although Arc was clearly detected in dendritic spines, no
colocalization with calnexin was observed in spines (Figure 3C).
In the DG of live rats, the Arc/calnexin PLA signal was
significantly increased in the GCL at 2 h after LTP-inducing
stimulation of the perforant path input. In the dendritic ML, the
PLA signal was unchanged despite maximal Arc expression at
this time (Messaoudi et al., 2007), suggesting that the primary
interaction of Arc with calnexin occurs in granule cell somata
(Figures 4C,D). It appears that Arc interacts with calnexin in
the basal state, prior to experimental induction of Arc by BDNF,
raising the possibility that Arc is stably associated with calnexin
at the ER. This is consistent with an ultrastructural analysis
showing a pool of immunoperoxidase-labeled Arc protein along
ER membranes of granule cell somata and dendrites (Rodríguez
et al., 2005).
The best described molecular role of Arc involves
endocytosis, including homeostatic scaling (Shepherd et al.,
2006), mGluR-LTD (Park et al., 2008) and its interaction with
clathrin adaptor protein AP-2, dynamin-2 and endophilin
2/3 to selectively internalize AMPARs (Chowdhury et al., 2006;
DaSilva et al., 2016). In contrast, the cytoplasmic C-tail of
calnexin is a potent inhibitor of clathrin-mediated endocytosis
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FIGURE 6 | Schematic of the Arc-calnexin interaction. The C-terminal end of
Arc’s central linker region interacts with the cytoplasmic C-terminus of calnexin
in hippocampal neurons. The 3D structure from the Arc C-terminal domain is
from Zhang et al. (2015). The predicted structure of the Arc N-terminus and
linker region is from Myrum et al. (2015).
(Li et al., 2011). We hypothesized that in a calnexin-bound
state, Arc either promotes endocytosis by blocking the effect
of the calnexin C-tail or inhibits endocytosis by blocking the
interaction with the endocytic machinery. However, transferrin
uptake assays showed no significant effects of calnexin/Arc
overexpression compared to either calnexin or Arc alone
(Figure 5). Since overexpression of Arc alone does not affect
endocytosis rates in HeLa cells (Chowdhury et al., 2006), the
interaction with calnexin may require another adaptor protein
to affect endocytosis.
The region of calnexin binding is critical for multiple Arc
protein-protein interactions and regulation. The C-terminal
end of the putative linker region binds AP-2 and dynamin 2
(Shepherd et al., 2006; DaSilva et al., 2016), and ERK-catalyzed
phosphorylation of S206 regulates the subcellular localization of
Arc (Nikolaienko et al., 2017b). The adjacent Arc C-terminal
domain is a bilobar structure in which the ‘‘N-lobe’’ region
(207–278) is an interaction site for several proteins, including
TARPγ2, αCaMKII, GKAP, WAVE1, IQSEC2 and GluN2A/B
(Zhang et al., 2015). One of these proteins, TARPγ2, belongs
to a family of AMPAR-binding auxiliary subunits intimately
involved in AMPAR function including surface expression,
synaptic targeting, as well as processing AMPARs in the ER and
promoting their exit from the ER (Vandenberghe et al., 2005;
Haering et al., 2014). The ER too is able to tune the spatial
dimensions of AMPAR surface expression and accumulation
at synapses (Ramírez and Couve, 2011; Cui-Wang et al.,
2012), and calnexin itself binds several receptors, including
AMPARs (Rubio and Wenthold, 1999). Arc’s interaction with
both an inhibitor of endocytosis (calnexin) as well as endocytic
machinery (dynamin-2, endophilin 2/3 and TARPγ2) points to
Arc’s role as a molecular switch to regulate these processes.
In addition to calnexin’s role in receptor trafficking, it
will be interesting to explore whether Arc is involved in the
canonical functions of calnexin as a chaperone and regulator of
protein quality control. It is also possible that the Arc/calnexin
interaction is involved in calnexin’s less characterized pathways.
For example, calnexin is actively recruited to the plasma
membrane in an NMDAR-dependent manner, indicating that
calnexin is involved in the trafficking of synaptic proteins to the
plasmamembrane (Itakura et al., 2013). Calnexin is continuously
endocytosed, but it is sent to lysosomes for degradation instead to
the pool of recycling endosomes (Okazaki et al., 2000). Evidence
also suggests that the calnexin C-tail acts as a calcium sensor
(Roderick et al., 2000), and such sensors are thought to regulate
receptor trafficking to control synaptic strength (Turrigiano,
2008). Finally, calnexin directly interacts with sarco endoplasmic
reticulum calcium ATPase (SERCA; Roderick et al., 2000), which
sequesters cytosolic calcium back to the ER (Treiman et al., 1998),
by which it determines ER calcium content (Lynes et al., 2013).
In summary, we establish here that: (1) Arc interacts with
calnexin, an integral ER chaperone protein; (2) the region
of Arc already known to be a binding hub also interacts
with calnexin; (3) Arc binds to the small cytosolic domain of
calnexin; (4) the Arc-calnexin association is significantly elevated
following stimulation in hippocampal neuron cell bodies and
dendritic shafts; (5) the Arc-calnexin association is significantly
elevated in the dentate granule cell somata following in vivoHFS
of the perforant path input; and (6) the interaction does not
appear to play a role in receptor endocytosis.
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